Targeted radiation therapy tested in teens with rare cancers
NCT ID NCT04711135
Summary
This study is testing the safety and measuring the radiation dose of a drug called Lutathera in teenagers (ages 12 to 18) with specific rare tumors. Lutathera is a targeted radiation therapy that seeks out and delivers radiation to tumor cells. The main goals are to see how much radiation reaches key organs and to monitor side effects in this younger age group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHEOCHROMOCYTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Léon Berard
Lyon, France
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
Cincinnati Children's Hospital
Cincinnati, Ohio, 45229-3039, United States
-
Hospital Universitari Vall d'Hebron
Barcelona, Spain
-
Maria Sklodowska-Curie National Research Institute of Oncology
Gliwice, Poland
-
University College Hospital of London
London, United Kingdom
-
University of Kentucky
Lexington, Kentucky, 40536, United States
Conditions
Explore the condition pages connected to this study.